Search for: "Yates v. Yates" Results 181 - 200 of 571
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Feb 2017, 2:54 pm by Quinta Jurecic
Jack Goldsmith and Marty Lederman, who have both served in senior positions in the Office of Legal Counsel, penned responses—Jack criticizing Yates's actions and Marty defending them. [read post]
27 Jan 2017, 6:08 am
Savarese, Wachtell, Lipton, Rosen & Katz, on Wednesday, January 25, 2017 Tags: Anti-corruption, Compliance & ethics, Cybersecurity, DOJ, Donald Trump, FCPA, International governance, Money laundering, Panama Papers, Risk oversight, SEC enforcement, Securities enforcement, Switzerland, Tax avoidance, Taxation, Whistleblowers, Yates memo Solera Underscores (Again) Difficulties of Challenging a Transaction Approved by Disinterested Stockholders Posted by Gail Weinstein and Matthew… [read post]
4 Dec 2016, 12:02 am by Mark Summerfield
  The matter was heard before Justices Perram, Jagot and Beach on 14 and 15 November 2016, and judgment handed down on 22 November 2016: Upaid Systems Ltd v Telstra Corporation Limited [2016] FCAFC 158.The Full Court has delivered a glimmer of hope to Upaid, partially granting leave to appeal, and allowing the appeal in relation to the primary judge’s order in relation to the ‘853 patent. [read post]
18 Nov 2016, 12:44 am by John Collins
Swiss Claims – Direct Infringement In the Australian proceedings, the Court affirmed Justice Yates’ approach in Otsuka Pharmaceutical Co Ltd v Generic Health Pty Ltd (No 4) (2015) 113 IPR 191, namely that the question of infringement of Swiss type claims was viewed through the prism of paragraph (b) of the definition of “exploit” in Schedule 1 of the Patents Act, which extends infringement to the use of the claimed method via a product resulting from such… [read post]
20 Oct 2016, 9:13 am by Kevin LaCroix
Having reviewed the history of the matter under factor (iii) he then turned to consider factor (v). [read post]
14 Oct 2016, 6:05 am
Martin, McDermott Will & Emery LLP, on Tuesday, October 11, 2016 Tags: Accountability, Compliance & ethics, DOJ, False Claims Act, Indemnification, Liability standards, Misconduct,Securities enforcement, Settlements, Yates memo It’s Commonsense to Have a U.S. [read post]
16 Sep 2016, 4:07 am by John Collins
Previously, the Full Court in Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2 (BMS) upheld Justice Yates’ ruling at first instance that the grant of an ‘exclusive licence’ meant an exclusive licence to undertake all of the activities within the meaning of “exploit” as defined in the Patents Act. [read post]